Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 656 of 6351
-
Implantable pump could ease diabetes management for 40 patients
Disease control Recruiting nowThe purpose of this study is to evaluate the clinical performance of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in adult patients with Type 1 diabetes mellitus that cannot be controlled with subcutaneous insulin therapy (including external pump), and presenting wi…
Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for kids with rare lung cancer: tailored chemo trial launches
Disease control Recruiting nowThis phase III trial tests how well surgery plus chemotherapy compared to surgery alone works in treating patients with type I pleuropulmonary blastoma (PPB), and tests how well surgery plus standard chemotherapy with the addition of topotecan works compared to surgery plus stand…
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New targeted drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThe study treatment, BAY 3713372, is under development to treat MTAP (methylthioadenosine phosphorylase)-deleted solid tumors. It is thought to work by blocking the protein arginine N-methyltransferase 5 (PRMT5). This may kill the MTAP-deleted cancer cells while sparing the norma…
Phase 1/2 • Sponsor: Bayer • Aim: Disease control
Last updated Sep 10, 2026 08:00 UTC
-
New asthma shot could help those failed by inhalers
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, parallel-group, placebo-controlled Phase III clinical trial designed to evaluate the efficacy and safety of TQC2731 injection (420 mg Q4W) in adult subjects with inadequately controlled severe asthma. A total of 660 trial par…
Phase 3 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Digital coach in the ER could boost addiction treatment rates
Disease control Recruiting nowThis study refines and optimizes the EMBED\* clinical decision support (CDS; see NCT03658642) to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder. This study does not have open en…
Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New HIV drug candidate targets resistant strains
Disease control OngoingThis trial is a randomized, double-blind, placebo-controlled clinical study conducted in treatment-experienced adults with NNRTI-resistant HIV-1, designed to preliminarily evaluate the efficacy, safety, and resistance profile of the core drug ACC017 in this population. The study…
Phase 1/2 • Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can AI and Tooth-Derived grafts make dental implants more precise?
Disease control CompletedThe integration of artificial intelligence and computer-guided technology offers the potential for improving surgical accuracy, reducing complications, and enhancing outcomes. Additionally, advancements such as electromagnetic mallets for bone manipulation and autologous dentin g…
Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat muscle disease
Disease control Recruiting nowThis single-arm, open-label, phase I trial evaluates the safety and tolerability of ICG318 CAR-T (BCMA-CD19-IL-15/IL15sushi cCAR T cells) in patients with refractory Idiopathic inflammatory myopathy (IIM).
Phase 1 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Simple blood test may spot postpartum depression risk during pregnancy
Diagnosis Recruiting nowThe goal of this observational study is to develop a blood test that may be predictive of postpartum depression. This Blood test is investigational and not yet FDA approved. Participants will not receive the results of this blood test. Up to 500 pregnant women will be recruited …
Sponsor: University of Virginia • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Can new scans catch lung transplant failure before It's too late?
Diagnosis Recruiting nowThis studies purpose is to confirm the efficacy and efficiency of using OE-MRI and MRI with hyperpolarized gas techniques and Iodinated contrast CT scan, this will enhance understanding of CLAD pathophysiology. Moreover, this project is foundational to performing additional studi…
Phase 1/2 • Sponsor: Sean Fain • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Custom-Made cancer vaccine targets leftover disease after surgery
Vaccine Recruiting nowThis is a phase 1 clinical trial to evaluate the safety, feasibility and immunogenicity of a personalized cancer vaccine strategy in patients with solid tumors and molecular residual disease. The hypothesis of the trial is that synthetic long peptide personalized cancer vaccines …
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Vaccine
Last updated Jul 19, 2026 00:00 UTC
-
Lung cancer combo aims to wipe out tumors before surgery
Disease control Recruiting nowThe main goals are after treatment given before surgery, to measure the number of people who have no signs of cancer cells in tumors and lymph nodes removed during surgery; and to learn about whether the cancer gets smaller or goes away by measuring the number of people with a ce…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can ancient chinese exercises outperform modern sports training for neck pain?
Symptom relief CompletedCervical spondylotic radiculopathy (CSR) is now becoming one of the most common public health concerns in the world. The objective of the current study is to compare the effects of Ba Duan Jin with the National Academy of Sports Medicine-based exercise protocol on pain, range of …
Sponsor: Rashid Latif Medical College • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Triple threat: new combo aims to boost kidney cancer treatment
Disease control Recruiting nowThis is a phase 2 stratified, randomized, multicenter, study investigating the efficacy of a triplet arm treating with nivolumab 480 mg every 4 weeks (Q4W), relatlimab 160 mg Q4W and ipilimumab 1 mg/kg every 8 weeks (Q8W) intravenous (IV) versus a doublet arm treating with nivolu…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New pill could clear psoriasis skin in major trial
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study to evaluate the efficacy, safety, PK characteristics of ICP-488 in Chinese adults with moderate to severe plaque psoriasis.
Phase 3 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New combo aims to tackle lymphoma that survives CAR-T
Disease control Recruiting nowThe purpose of the study is to evaluate the safety and efficacy of tafasitamab and lenalidomide in participants with Large B Cell Lymphoma (LBCL) after axicabtagene ciloleucel (axi-cel) treatment. Participants will be asked to spend about 12 months in this study.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy aims to wipe out prostate tumors before surgery
Disease control Recruiting nowThe high incidence of prostate cancer is one of the important diseases that threaten the health of old men in our country. Although androgen deprivation therapy is an important treatment option for prostate cancer, although neoadjuvant androgen deprivation therapy combined with r…
Phase 2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 26, 2026 14:51 UTC
-
New Three-Drug cocktail aims to outsmart tough leukemia
Disease control Recruiting nowThis research study will test the safety and anticancer activity of the combination of three drugs (Roginolisib, Venetoclax, and Rituximab) for participants with relapsed or refractory Chronic Lymphocytic Leukemia (CLL). The names of the study drugs involved in this study are: …
Phase 1/2 • Sponsor: Jennifer R. Brown, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can an experimental pill lift the fog of severe depression? a new trial puts KH607 to the test.
Symptom relief CompletedThis is a two-part (open-label followed by double-blind) study evaluating the safety, tolerability, pharmacokinetics, and efficacy of KH607 in 120 participants diagnosed with moderate or severe Major Depressive Disorder.
Phase 2 • Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd. • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
New drug duo aims to keep ovarian cancer at bay longer
Disease control Recruiting nowThis clinical trial is designed to evaluate the efficacy and safety of T-DXd in combination with bevacizumab versus bevacizumab monotherapy as first-line maintenance therapy, in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2…
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC